Markus Thomas

Person

Penzberg, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies
- Patent number 9,708,396
- Issue date Jul 18, 2017
- Hoffmann-La Roche Inc.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies
- Patent number 8,945,552
- Issue date Feb 3, 2015
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies
- Patent number 8,703,130
- Issue date Apr 22, 2014
- Hoffmann-La Roche, Inc.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-VEGF/anti-ANG-2 antibodies
- Patent number 8,268,314
- Issue date Sep 18, 2012
- Hoffmann-La Roche Inc.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20230399391
- Publication date Dec 14, 2023
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20210047394
- Publication date Feb 18, 2021
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- Publication number 20200199215
- Publication date Jun 25, 2020
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST
- Publication number 20180134780
- Publication date May 17, 2018
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20170369566
- Publication date Dec 28, 2017
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20170240626
- Publication date Aug 24, 2017
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy with an anti-ANG2 antibody and a CD40 agonist
- Publication number 20150232548
- Publication date Aug 20, 2015
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG2 ANTIBODIES
- Publication number 20150191535
- Publication date Jul 9, 2015
- HOFFMANN-LA ROCHE INC.
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20150004166
- Publication date Jan 1, 2015
- Hoffmann-La Roche Inc.
- Monika Baehner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20120321627
- Publication date Dec 20, 2012
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20110236388
- Publication date Sep 29, 2011
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES
- Publication number 20100111967
- Publication date May 6, 2010
- Monika Baehner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Markus Thomas

Person

Patents Grantslast 30 patents

Bispecific anti-VEGF/anti-ANG-2 antibodies

Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies

Bispecific anti-VEGF/anti-ANG-2 antibodies

Bispecific anti-VEGF/anti-ANG-2 antibodies

Patents Applicationslast 30 patents

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST

COMBINATION THERAPY WITH AN ANTI-ANG2 ANTIBODY AND A CD40 AGONIST

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

Combination therapy with an anti-ANG2 antibody and a CD40 agonist

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG2 ANTIBODIES

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES